All Articles
Perspective
With Adobe’s proposed $20 billion acquisition, Figma’s tale of disruption is a Cinderella story. Unique insights informed the company’s product decisions, allowing it to…
PortfolioFunding
Evolving Pricing and Scaling Revenue: Our Series A Investment in Orb
Nailing your monetization strategy has become more important than ever in today’s weakened macroeconomic climate, and it’s no longer as simple as charging per…
PerspectivePortfolio
Video: Early Cancer Detection With Delfi
Delfi Diagnostics has developed a test that combines ultra-low-cost sequencing and machine learning to detect cancer early.
PortfolioPerspective
Video: Reengineering Drug Discovery With Recursion
Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.
PortfolioFunding
Our Investment in Typeface: Generative AI at Enterprise Speed and Scale
Since the advent of the internet, few technological advances have garnered as much attention and enthusiasm as quickly as generative AI.
PortfolioFunding
Hat Trick: Menlo’s Third Investment in Finch in Three Years
Congratulations to Jeremy Zhang, Ansel Parikh, and the Finch team on raising their Series B! For Menlo, it’s an exciting milestone, marking the third…
Perspective
Video: Supply Chain Resiliency—From Robotics and Automation to Visibility
At Manifest 2023, Menlo’s Steve Sloane moderated a panel with top supply chain experts to discuss current trends and shifts within the industry, as…
PortfolioPerspective
Menlo’s Fintech Outlook for 2023
At Menlo Ventures, we’ve invested in fintech for a long time and, despite the volatility of the last two years, believe there’s still a…
PerspectiveHow To
A Talent Partner’s Advice on Job Seeking in a Down Market
Landing a new role in this market can feel daunting. But it’s not all doom and gloom for job seekers.
PerspectivePortfolioHow To
Back to Basics: Fundamentals for Building Breakout Consumer Companies
Economic downturns force us to get back to basics: The cost of new capital and low valuation multiples—even for top-performing public companies—force startups to…
PortfolioPerspectiveFunding
Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna
Cancer remains one of the leading causes of death in the U.S. and worldwide.
Perspective
Perspectives for 2023 from Supply Chain Leaders at Uber, Maersk, and P&G
Supply chain is having a moment.